These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 12713577)
21. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Goates CY; Knutson K Biochim Biophys Acta; 1994 Oct; 1195(1):169-79. PubMed ID: 7918560 [TBL] [Abstract][Full Text] [Related]
22. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. Anigbogu AN; Williams AC; Barry BW J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983 [TBL] [Abstract][Full Text] [Related]
23. An integrated pharmacokinetic and imaging evaluation of vehicle effects on solute human epidermal flux and, retention characteristics. Winckle G; Anissimov YG; Cross SE; Wise G; Roberts MS Pharm Res; 2008 Jan; 25(1):158-66. PubMed ID: 17891555 [TBL] [Abstract][Full Text] [Related]
24. Enhancing effect of N-dodecyl-2-pyrrolidone on the percutaneous absorption of 5-fluorouracil derivatives. Sato S; Hirotani Y; Ogura N; Sasaki E; Kitagawa S Chem Pharm Bull (Tokyo); 1998 May; 46(5):831-6. PubMed ID: 9621418 [TBL] [Abstract][Full Text] [Related]
25. Effect of barrier disruption by acetone treatment on the permeability of compounds with various lipophilicities: implications for the permeability of compromised skin. Tsai JC; Sheu HM; Hung PL; Cheng CL J Pharm Sci; 2001 Sep; 90(9):1242-54. PubMed ID: 11745777 [TBL] [Abstract][Full Text] [Related]
26. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. Singh P; Roberts MS J Pharmacol Exp Ther; 1994 Jan; 268(1):144-51. PubMed ID: 8301551 [TBL] [Abstract][Full Text] [Related]
27. Effect of solute lipophilicity on penetration through canine skin. Mills PC; Magnusson BM; Cross SE Aust Vet J; 2003 Dec; 81(12):752-5. PubMed ID: 15080487 [TBL] [Abstract][Full Text] [Related]
28. Thermodynamic and kinetic analysis of human epidermal penetration of phenolic compounds: I. Stratum corneum solubility and partitioning. Alinaghi A; Zhang Q; Williams DB; Mackenzie L; Roberts MS Int J Pharm; 2023 Jan; 630():122424. PubMed ID: 36427696 [TBL] [Abstract][Full Text] [Related]
29. Tissue binding affects the kinetics of theophylline diffusion through the stratum corneum barrier layer of skin. Frasch HF; Barbero AM; Hettick JM; Nitsche JM J Pharm Sci; 2011 Jul; 100(7):2989-95. PubMed ID: 21283983 [TBL] [Abstract][Full Text] [Related]
30. Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents. Wagner H; Kostka KH; Lehr CM; Schaefer UF J Control Release; 2001 Aug; 75(3):283-95. PubMed ID: 11489316 [TBL] [Abstract][Full Text] [Related]
31. The effect of structural QSAR parameters on skin penetration. Ghafourian T; Fooladi S Int J Pharm; 2001 Apr; 217(1-2):1-11. PubMed ID: 11292537 [TBL] [Abstract][Full Text] [Related]
32. Skin penetration of nonsteroidal antiinflammatory drugs out of a lipophilic vehicle: influence of the viable epidermis. Wenkers BP; Lippold BC J Pharm Sci; 1999 Dec; 88(12):1326-31. PubMed ID: 10585230 [TBL] [Abstract][Full Text] [Related]
33. In vitro human topical bioactive drug transdermal absorption: estradiol. Xing MM; Hui X; Zhong W; Pan N; Yaghmaie F; Maibach HI Cutan Ocul Toxicol; 2009; 28(4):171-5. PubMed ID: 19888886 [TBL] [Abstract][Full Text] [Related]
34. Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure. Dancik Y; Miller MA; Jaworska J; Kasting GB Adv Drug Deliv Rev; 2013 Feb; 65(2):221-36. PubMed ID: 22285584 [TBL] [Abstract][Full Text] [Related]
35. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes. Rim JE; Pinsky PM; van Osdol WW J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598 [TBL] [Abstract][Full Text] [Related]
36. Estimation of skin concentrations of topically applied lidocaine at each depth profile. Oshizaka T; Kikuchi K; Kadhum WR; Todo H; Hatanaka T; Wierzba K; Sugibayashi K Int J Pharm; 2014 Nov; 475(1-2):292-7. PubMed ID: 25158219 [TBL] [Abstract][Full Text] [Related]
37. Effects of isopropanol-isopropyl myristate binary enhancers on in vitro transport of estradiol in human epidermis: a mechanistic evaluation. Liu P; Cettina M; Wong J J Pharm Sci; 2009 Feb; 98(2):565-72. PubMed ID: 18563737 [TBL] [Abstract][Full Text] [Related]
38. Effects of UVA (320-400 nm) on the barrier characteristics of the skin. McAuliffe DJ; Blank IH J Invest Dermatol; 1991 May; 96(5):758-62. PubMed ID: 2022882 [TBL] [Abstract][Full Text] [Related]
39. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. Anissimov YG; Roberts MS J Pharm Sci; 2004 Feb; 93(2):470-87. PubMed ID: 14705203 [TBL] [Abstract][Full Text] [Related]
40. An updated database of human maximum skin fluxes and epidermal permeability coefficients for drugs, xenobiotics, and other solutes applied as aqueous solutions. Cheruvu HS; Liu X; Grice JE; Roberts MS Data Brief; 2022 Jun; 42():108242. PubMed ID: 35599823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]